Given that B56γ3 upregulates AKT activity and that hyperactive PI3K/AKT signaling has been linked to multidrug resistance in a variety of cancer types [31, 32], next, we investigated whether B56γ3 played a role in regulating cancer cell survival upon chemotherapeutic drug treatment. The gene discussed is AKT1; the disease is cancer.